COM:GLENMARKPHARMA
Glenmark Pharmaceuticals
- Stock
Last Close
1,466.40
22/11 07:20
Market Cap
390.66B
Beta: -
Volume Today
321.07K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Mar '14 | Mar '15 | Mar '16 | Mar '17 | Mar '18 | Mar '19 | Mar '20 | Mar '21 | Mar '22 | Mar '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
average inventory | 8.88B - | 11.01B 23.95% | 14.18B 28.83% | 18.53B 30.67% | 20.85B 12.49% | 21.41B 2.71% | 21.94B 2.45% | 22.06B 0.56% | 23.88B 8.25% | 27.39B 14.67% | |
average payables | 12.00B - | 17.04B 42.00% | 20.26B 18.90% | 19.55B 3.51% | 18.87B 3.50% | 20.45B 8.41% | 21.73B 6.26% | 21.82B 0.39% | 22.63B 3.73% | 23.40B 3.40% | |
average receivables | 15.10B - | 15.10B 0% | 16.86B 11.65% | 34.47B 104.42% | 17.61B 48.92% | 13.20B - | 33.51B 153.82% | 40.80B 21.75% | |||
book value per share | 110.07 - | 110.61 0.48% | 152.11 37.53% | 175.05 15.08% | 198.08 13.15% | 212.47 7.27% | 215.14 1.26% | 250.37 16.38% | 322.03 28.62% | 335.62 4.22% | |
capex per share | -13.90 - | -20.06 44.39% | -31.71 58.06% | -26.53 16.35% | -37.02 39.56% | -43.85 18.43% | -33.01 24.72% | -27.46 16.82% | -28.00 1.98% | -21.53 23.11% | |
capex to depreciation | -1.74 - | -2.09 20.51% | -3.31 58.00% | -1.30 60.75% | -2.95 127.24% | -2.26 23.28% | -2.23 1.37% | -1.75 21.76% | -1.62 7.06% | -0.99 38.75% | |
capex to operating cash flow | -0.44 - | -1.13 156.14% | -2.58 128.47% | -1.14 55.90% | -0.63 44.33% | -0.93 47.40% | -0.67 28.41% | -0.68 2.39% | -0.71 4.06% | -0.97 36.36% | |
capex to revenue | -0.06 - | -0.08 31.26% | -0.12 42.17% | -0.08 28.83% | -0.12 38.31% | -0.13 9.14% | -0.09 29.73% | -0.07 19.96% | -0.06 9.48% | -0.05 26.41% | |
cash per share | 29.87 - | 28.55 4.42% | 31.06 8.77% | 35.61 14.68% | 50.06 40.57% | 40.16 19.78% | 41.82 4.13% | 43.04 2.93% | 51.15 18.85% | 58.23 13.83% | |
days of inventory on hand | 178.07 - | 235.60 32.30% | 238.71 1.32% | 293.53 22.96% | 238.35 18.80% | 241.23 1.21% | 206.95 14.21% | 221.98 7.26% | 204.60 7.83% | 239.56 17.09% | |
days payables outstanding | 260.09 - | 379.78 46.01% | 305.53 19.55% | 261.21 14.51% | 219.47 15.98% | 237.87 8.38% | 206.00 13.40% | 218.17 5.91% | 187.31 14.14% | 192.43 2.73% | |
days sales outstanding | 186.10 - | 164.05 - | 145.00 11.61% | 89.20 - | 121.79 36.54% | 117.56 3.47% | |||||
debt to assets | 0.38 - | 0.39 3.66% | 0.36 8.43% | 0.39 7.68% | 0.36 7.89% | 0.33 8.72% | 0.35 8.59% | 0.32 9.52% | 0.23 27.42% | 0.24 2.99% | |
debt to equity | 1.10 - | 1.27 15.65% | 0.93 26.26% | 0.96 2.40% | 0.83 13.20% | 0.74 10.61% | 0.85 15.13% | 0.71 17.39% | 0.44 38.22% | 0.49 12.02% | |
dividend yield | 0.00 - | 0.00 27.86% | 0.00 2.15% | 0.00 7.24% | 0.00 55.82% | 0.00 16.18% | 0.01 220.44% | 0.01 54.48% | 0.01 38.34% | 0.01 40.12% | |
earnings yield | 0.04 - | 0.02 37.04% | 0.03 41.14% | 0.04 21.11% | 0.05 31.56% | 0.05 3.47% | 0.13 176.13% | 0.07 44.62% | 0.08 2.06% | 0.02 69.99% | |
enterprise value | 177.91B - | 243.62B 36.93% | 254.50B 4.47% | 277.11B 8.88% | 188.53B 31.96% | 219.42B 16.38% | 98.84B 54.95% | 169.60B 71.59% | 150.23B 11.42% | 163.02B 8.51% | |
enterprise value over ebitda | 16.14 - | 23.33 44.52% | 17.52 24.90% | 13.37 23.67% | 11.03 17.50% | 12.24 10.90% | 5.32 56.54% | 7.95 49.45% | 6.03 24.18% | 6.28 4.26% | |
ev to operating cash flow | 20.84 - | 50.58 142.70% | 73.80 45.92% | 42.15 42.89% | 11.44 72.86% | 16.57 44.85% | 7.10 57.16% | 14.99 111.21% | 13.55 9.62% | 26.07 92.36% | |
ev to sales | 3.00 - | 3.74 24.38% | 3.39 9.20% | 3.13 7.83% | 2.11 32.57% | 2.26 7.25% | 0.95 57.95% | 1.57 65.10% | 1.23 21.37% | 1.28 3.81% | |
free cash flow per share | 17.60 - | -2.31 113.11% | -19.43 741.91% | -3.23 83.38% | 21.38 762.38% | 3.08 85.58% | 16.34 429.93% | 12.63 22.68% | 11.29 10.64% | 0.62 94.47% | |
free cash flow yield | 0.03 - | -0.00 109.43% | -0.02 732.49% | -0.00 84.50% | 0.04 1,130.99% | 0.00 87.92% | 0.08 1,581.44% | 0.03 65.75% | 0.03 6.05% | 0.00 94.74% | |
graham net net | -77.33 - | -194.58 151.63% | -94.32 51.53% | -90.64 3.90% | -177.35 95.66% | -192.25 8.40% | -225.64 17.37% | -149.06 33.94% | -67.52 54.70% | -117.82 74.48% | |
graham number | 222.60 - | 208.82 6.19% | 292.57 40.11% | 357.57 22.22% | 349.68 2.21% | 388.67 11.15% | 364.85 6.13% | 440.08 20.62% | 491.75 11.74% | 281.99 42.66% | |
income quality | 1.23 - | 0.81 33.84% | 0.34 57.65% | 0.52 52.00% | 1.54 196.12% | 1.05 31.86% | 1.27 20.69% | 0.82 35.59% | 0.77 5.99% | 0.72 6.38% | |
intangibles to total assets | 0.15 - | 0.13 15.00% | 0.14 3.12% | 0.11 19.32% | 0.12 6.22% | 0.14 22.80% | 0.15 4.33% | 0.15 0.70% | 0.13 10.60% | 0.13 6.07% | |
interest coverage | 4.66 - | 4.12 11.63% | 6.57 59.66% | 6.23 5.18% | 4.70 24.53% | 4.75 1.01% | 3.82 19.59% | 4.79 25.31% | 6.73 40.60% | 5.68 15.70% | |
interest debt per share | 127.50 - | 147.09 15.37% | 148.44 0.91% | 175.82 18.45% | 174.54 0.73% | 169.52 2.88% | 197.16 16.31% | 189.21 4.03% | 150.98 20.20% | 176.31 16.78% | |
inventory turnover | 2.05 - | 1.55 24.42% | 1.53 1.31% | 1.24 18.67% | 1.53 23.15% | 1.51 1.19% | 1.76 16.56% | 1.64 6.77% | 1.78 8.50% | 1.52 14.60% | |
invested capital | 1.10 - | 1.27 15.65% | 0.93 26.26% | 0.96 2.40% | 0.83 13.20% | 0.74 10.61% | 0.85 15.13% | 0.71 17.39% | 0.44 38.22% | 0.49 12.02% | |
market cap | 153.19B - | 213.25B 39.21% | 223.19B 4.66% | 240.43B 7.73% | 154.47B 35.75% | 184.30B 19.31% | 58.08B 68.48% | 131.12B 125.75% | 124.72B 4.88% | 131.18B 5.18% | |
net current asset value | -8.74B - | -13.64B 56.01% | -9.23B 32.33% | -3.98B 56.85% | -4.44B 11.36% | -9.87B 122.54% | -18.11B 83.46% | -11.80B 34.86% | 6.37B 154.01% | 3.41B 46.44% | |
net debt to ebitda | 2.24 - | 2.91 29.62% | 2.16 25.86% | 1.77 17.88% | 1.99 12.63% | 1.96 1.74% | 2.19 11.95% | 1.80 17.78% | 1.02 43.24% | 1.23 19.91% | |
net income per share | 20.01 - | 17.52 12.42% | 25.01 42.73% | 32.46 29.80% | 27.44 15.48% | 31.60 15.17% | 27.50 12.97% | 34.38 25.02% | 33.37 2.93% | 10.53 68.45% | |
operating cash flow per share | 31.50 - | 17.76 43.63% | 12.28 30.82% | 23.30 89.67% | 58.41 150.68% | 46.93 19.65% | 49.35 5.15% | 40.09 18.76% | 39.29 1.99% | 22.15 43.61% | |
payables turnover | 1.40 - | 0.96 31.51% | 1.19 24.30% | 1.40 16.97% | 1.66 19.02% | 1.53 7.74% | 1.77 15.47% | 1.67 5.58% | 1.95 16.47% | 1.90 2.66% | |
receivables turnover | 1.96 - | 2.22 - | 2.52 13.14% | 4.09 - | 3.00 26.76% | 3.10 3.59% | |||||
research and ddevelopement to revenue | |||||||||||
return on tangible assets | 0.07 - | 0.06 23.97% | 0.07 29.50% | 0.08 15.13% | 0.07 20.12% | 0.08 13.01% | 0.06 18.35% | 0.07 17.80% | 0.06 12.96% | 0.02 72.42% | |
revenue per share | 218.56 - | 240.42 10.00% | 267.27 11.17% | 314.13 17.53% | 316.96 0.90% | 343.95 8.51% | 368.48 7.13% | 382.96 3.93% | 431.45 12.66% | 450.80 4.49% | |
roe | 0.18 - | 0.16 12.85% | 0.16 3.79% | 0.19 12.79% | 0.14 25.30% | 0.15 7.37% | 0.13 14.05% | 0.14 7.42% | 0.10 24.53% | 0.03 69.73% | |
roic | 0.11 - | 0.09 16.36% | 0.10 8.04% | 0.11 11.85% | 0.10 14.33% | 0.11 13.19% | 0.09 18.27% | 0.10 8.94% | 0.10 7.95% | 0.06 42.19% | |
sales general and administrative to revenue | 0.02 - | 0.02 30.58% | 0.03 5.62% | 0.03 2.64% | 0.02 7.68% | 0.03 22.58% | 0.04 23.74% | 0.03 16.38% | 0.03 12.10% | 0.02 27.42% | |
shareholders equity per share | 110.07 - | 110.61 0.48% | 152.11 37.53% | 175.05 15.08% | 198.08 13.15% | 212.47 7.27% | 215.14 1.26% | 250.37 16.38% | 322.03 28.62% | 335.62 4.22% | |
stock based compensation to revenue | -0.00 - | 0.00 159.65% | 0.00 - | 0.00 98.91% | 0.00 2,590.37% | 0.00 147.62% | 0.00 11.47% | 0.00 18.13% | |||
tangible asset value | 16.63B - | 17.29B 3.92% | 27.67B 60.08% | 36.06B 30.29% | 40.78B 13.12% | 40.47B 0.78% | 38.88B 3.92% | 47.29B 21.64% | 71.53B 51.24% | 74.05B 3.53% | |
tangible book value per share | 61.38 - | 63.73 3.83% | 98.57 54.68% | 127.78 29.63% | 144.54 13.11% | 143.41 0.78% | 137.79 3.92% | 167.61 21.64% | 253.49 51.24% | 262.32 3.48% | |
working capital | 18.14B - | 16.12B 11.11% | 19.08B 18.35% | 41.71B 118.61% | 37.01B 11.27% | 26.76B 27.70% | 26.78B 0.07% | 31.59B 17.96% | 35.93B 13.75% | 48.28B 34.38% |
All numbers in (except ratios and percentages)